Funding · Company
Angiex, Inc.
Cambridge, MABiotech & Pharma
Angiex, Inc. of Cambridge, MA has disclosed $22M across 1 Form D offering filed with the SEC on Sep 26, 2025.
$22M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$22M
Form D · Sep 26, 2025 ↗
Q3 2025
· 1 amendment, first filed Aug 14, 2025
· target $28M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001710380Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →